Does hypothalamic-pituitary-adrenal axis hypofunction in chronic fatigue syndrome reflect a 'crash' in the stress system?

Medical Hypotheses

Volumn 72, Issue 6, 2009, Pages 701-705

  Van Houdenhove, Boudewijn ^a   Eede, Filip Van Den ^b   Luyten, Patrick ^c  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLUCOCORTICOID;

ARTICLE; CHRONIC FATIGUE SYNDROME; COGNITIVE THERAPY; CYTOKINE RELEASE; DEPRESSION; FIBROMYALGIA; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIFE STRESS; NEUROBIOLOGY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SLEEP DISORDER;

FATIGUE SYNDROME, CHRONIC; HUMANS; HYPOTHALAMIC DISEASES; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MODELS, IMMUNOLOGICAL; OXIDATIVE STRESS; PITUITARY-ADRENAL SYSTEM; STRESS, PHYSIOLOGICAL;

EID: 62949099218     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.11.044     Document Type: Article

References (93)

1. Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., and Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International chronic fatigue syndrome study group. Ann Intern Med 121 (1994) 953-959
2. Prins J.B., van der Meer J.W., and Bleijenberg G. Chronic fatigue syndrome. Lancet 367 (2006) 346-355
3. Cho H.J., Skowera A., Cleare A., and Wessely S. Chronic fatigue syndrome: an update focusing on phenomenology and pathophysiology. Curr Opin Psychiatry 19 (2006) 67-73
4. Van Houdenhove B., and Luyten P. Customizing treatment in chronic fatigue syndrome/fibromyalgia: the role of perpetuating factors. Psychosomatics 49 (2008) 470-477
5. Van Den Eede F., Moorkens G., Van Houdenhove B., Cosyns P., and Claes S.J. HPA axis function in chronic fatigue syndrome. Neuropsychobiology 55 (2007) 112-120
6. Jerjes W.K., Taylor N.F., Wood P.J., and Cleare A.J. Enhanced feedback sensitivity to prednisolone in chronic fatigue syndrome. Psychoneuroendocrinology 32 (2007) 192-198
7. Nater U.M., Youngblood L.S., Jones J.F., et al. Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome. Psychosom Med 70 (2008) 298-305
8. Nater U.M., Maloney E., Boneva R.S., et al. Attenuated morning salivary cortisol concentrations in a population-based study of persons with chronic fatigue syndrome and well controls. J Clin Endocrinol Metab 93 (2008) 703-709
9. Papadopoulos A., Ebrecht M., Roberts A.D.L., Poon L., Rohleder N., and Cleare A.J. Glucocorticoid receptor mediated negative feedback in chronic fatigue syndrome using the low dose (05 mg) dexamethasone suppression test. J Affect Dis (2008) 10.1016/j.jad.2008.05.00
10. Cleare A.J. The neuroendocrinology of chronic fatigue syndrome. Endocr Rev 24 (2003) 236-252
11. Cleare A.J. The HPA axis and the genesis of chronic fatigue syndrome. Trends Endocrinol Metab 15 (2004) 55-59
12. Gaab J., Engert V., Heitz V., Schad T., Schürmeyer T.H., and Ehlert U. Associations between neuroendocrine responses to the insulin tolerance test and patient characteristics in chronic fatigue syndrome. J Psychosom Res 56 (2004) 419-424
13. Candy B., Chalder T., Cleare A.J., et al. Predictors of fatigue following the onset of infectious mononucleosis. Psychol Med 33 (2003) 847-855
14. Rubin G.J., Hotopf M., Papadopoulos A., and Cleare A.J. Salivary cortisol as a predictor of post-operative fatigue. Psychosom Med 67 (2005) 441-447
15. Sharpley A., Clements A., Hawton K., and Sharpe M. Do patients with "pure" chronic fatigue syndrome (neurasthenia) have abnormal sleep?. Psychosom Med 59 (1997) 592-596
16. Vgontzas A.N., Bixler E.O., Lin H.M., et al. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab 86 (2001) 3787-3794
17. Boneva R.S., Decker M.J., Maloney E.M., et al. Higher heart rate and reduced heart rate variability persist during sleep in chronic fatigue syndrome: a population-based study. Auton Neurosci 137 (2007) 94-101
18. Jason L.A., Muldowney K., and Torres-Harding S. The energy envelope theory and myalgic encephalomyelitis/chronic fatigue syndrome. AAOHN J 56 (2008) 189-195
19. Van Houdenhove B., Neerinckx E., Onghena P., Lysens R., and Vertommen H. Premorbid "overactive" lifestyle in chronic fatigue syndrome and fibromyalgia. An etiological factor or proof of good citizenship?. J Psychosom Res 51 (2001) 571-576
20. Meeus M., Nijs J., Van de Wauwer N., Toeback L., and Truijen S. Diffuse noxious inhibitory control is delayed in chronic fatigue syndrome: an experimental study. Pain 139 (2008) 439-448
21. McLean S.A., Clauw D.J., Abelson J.L., and Liberzon I. The development of persistent pain and psychological morbidity after motor vehicle collision: integrating the potential role of stress response systems into a biopsychosocial model. Psychosom Med 67 (2005) 783-790
22. Hudson J.L., Arnold L.M., Keck Jr. P.E., Auchenbach M.B., and Pope Jr. H.G. Family study of fibromyalgia and affective spectrum disorder. Biol Psychiatry 56 (2004) 884-891
23. Narita M., Nishigami N., Narita N., et al. Association between serotonin transporter gene polymorphism and chronic fatigue syndrome. Biochem Biophys Res Commun 311 (2003) 264-366
24. Rajeevan M.S., Smith A.K., Dimulescu I., et al. Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome. Genes Brain Behav 6 (2007) 167-176
25. Cleare A.J., Messa C., Rabiner E.A., and Grasby P.M. Brain 5-HT1A receptor binding in chronic fatigue syndrome measured using positron emission tomography and [11C]WAY-100635. Biol Psychiatry 57 (2005) 239-246
26. Gold P.W., and Chrousos G.P. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs. low CRH/NE states. Mol Psychiatry 7 (2002) 254-275
27. Juruena M.F., and Cleare A.J. Overlap between atypical depression, seasonal affective disorder and chronic fatigue syndrome. Rev Bras Psiquiatr 29 Suppl. 1 (2007) S19-26
28. Van Houdenhove B., Neerinckx E., Lysens R., et al. Victimization in chronic fatigue syndrome and fibromyalgia in tertiary care: a controlled study on prevalence and characteristics. Psychosomatics 42 (2001) 21-28
29. Heim C., Wagner D., Maloney E., et al. Early adverse experience and risk for chronic fatigue syndrome: results from a population-based study. Arch Gen Psychiatry 63 (2006) 1258-1266
30. Kato K., Sullivan P.F., Evengard B., and Pedersen N.L. Premorbid predictors of chronic fatigue. Arch Gen Psychiatry 63 (2006) 1267-1272
31. Heim C., Newport D.J., Mletzko T., Miller A.H., and Nemeroff C.B. The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 33 (2008) 693-710
32. Heim C., Nater U.M., Maloney E., Boneva R., Jones J.F., and Reeves W.C. Childhood trauma and risk for chronic fatigue syndrome: association with neuroendocrine dysfunction. Arch Gen Psychiatry 66 (2009) 72-80
33. Van Den Eede F., Moorkens G., Hulstijn W., Van Houdenhove B., Cosyns P., and Sabbe B.C.G. Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome. Psychol Med 38 (2008) 963-973
34. Van Houdenhove B., and Luyten P. Fibromyalgia and related syndromes characterized by stress intolerance and pain hypersensitivity: do we need a new nosology?. Curr Rheumatol Rev 3 (2007) 304-308
35. McBeth J., Silman A., Gupta A., et al. Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain: findings of a population-based prospective cohort study. Arthritis Rheum 56 (2007) 360-371
36. Glass J.M., Lyden A.K., Petzke F., et al. The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals. J Psychosom Res 57 (2004) 391-398
37. Van Houdenhove B. Listening to CFS. Why we should pay more attention to the story of the patient. J Psychosom Res 52 (2002) 495-499
38. Luyten P., Van Houdenhove B., Cosyns N., and Van den Broeck A.L. Are patients with chronic fatigue syndrome perfectionistic - or were they? A case-control study. Pers Indiv Diff 40 (2006) 1473-1483
39. Van Campen E, Van Den Eede F, Moorkens G, et al. Assessment of personality in chronic fatigue syndrome with temperament and character inventory. Psychosomatics, in press.
40. Hatcher S., and House A. Life events, difficulties and dilemmas in the onset of chronic fatigue syndrome: a case-control study. Psychol Med 33 (2003) 1185-1192
41. Harvey S.B., Wadsworth M., Wessely S., and Hotopf M. Etiology of chronic fatigue syndrome: testing popular hypotheses using a national birth cohort study. Psychosom Med 70 (2008) 488-495
42. Yehuda R., and Bierer L.M. Transgenerational transmission of cortisol and PTSD risk. Prog Brain Res 167 (2008) 121-135
43. Harvey S.B., Wadsworth M., Wessely S., and Hotopf M. The relationship between prior psychiatric disorder and chronic fatigue: evidence from a national birth cohort study. Psychol Med 38 (2008) 933-940
44. Fries E. Hypocortisolemic disorders. In: Hellhammer D.H., and Hellhammer J. (Eds). Stress. The brain-body connection. Key issues in mental health vol. 174 (2008), Karger, Basel 60-77
45. Gupta S., Aslakson E., Gurbaxani B.M., and Vernon S.D. Inclusion of the glucocorticoid receptor in a hypothalamic pituitary adrenal axis model reveals bistability. Theor Biol Med Model 4 (2007) 8
46. Houshyar H., Galigniana M.D., Pratt W.B., and Woods J.H. Differential reponsivity of the hypothalamic-pituitary-adrenal axis to glucocorticoid negative feedback and corticotropin releasing hormone in rats undergoing morphine withdrawal: possible mechanisms involved in facilitated and attenuated stress responses. J Neuroendocrinol 13 (2001) 875-886
47. Miller G.E., Chen E., and Zhou E.S. If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans. Psychol Bull 133 (2007) 25-45
48. Chrousos G.P., and Kino T. Glucocorticoid action networks and complex psychiatric and/or somatic disorders. Stress 10 (2007) 213-219
49. McEwen B.S. Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol 583 (2008) 174-185
50. Fuite J., Vernon S.D., and Broderick G. Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis. Genomics (2008) 10.1016/j.jad.2008.09.01
51. Martinez-Lavin M., Infante O., and Lerma C. Hypothesis: the chaos and complexity theory may help our understanding of fibromyalgia and similar maladies. Semin Athritis Rheum 37 (2008) 260-264
52. Smith S.M., and Vale W.W. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci 8 (2006) 383-395
53. Elenkov I.J., and Chrousos G.P. Stress system - organization, physiology and immunoregulation. Neuroimmunomodulation 13 (2006) 257-267
54. Lanfumey L., Mongeau R., Cohen-Salmon C., and Hamon M. Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders. Neurosci Biobehav Rev 32 (2008) 1174-1184
55. Raison C.L., and Miller A.H. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry 160 (2003) 1554-1565
56. Miller G.E., Chen E., Sze J., et al. A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappa-B signalling. Biol Psychiatry 64 (2008) 266-272
57. Miller A.H. Inflammation versus glucocorticoids as purveyors of pathology during stress: have we reached the tipping point?. Biol Psychiatry 64 (2008) 263-265
58. Heijnen C.J. Receptor regulation in neuroendocrine-immune communication: current knowledge and future perspectives. Brain Behav Immun 21 (2007) 1-8
59. Kavelaars A., Kuis W., Knook L., Sinnema G., and Heijnen C.J. Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome. J Clin Endocrinol Metab 85 (2000) 692-696
60. ter Wolbeek M., van Doornen L.J., Schedlowski M., Janssen O.E., Kavelaars A., and Heijnen C.J. Glucocorticoid sensitivity of immune cells in severely fatigued adolescent girls: a longitudinal study. Psychoneuroendocrinology 33 (2008) 375-385
61. ter Wolbeek M., van Doornen L.J., Kavelaars A., van de Putte E.M., Schedlowski M., and Heijnen C.J. Longitudinal analysis of pro- and anti-inflammatory cytokine production in severely fatigued adolescents. Brain Behav Immun 21 (2007) 1063-1074
62. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci 933 (2001) 222-234
63. Viljoen M., and Panzer A. Non-termination of sickness behavior as precipitating factor for mental disorders. Med Hypoth 65 (2005) 316-329
64. Visser J., Lentjes E., Haspels I., et al. Increased sensitivity to glucocorticoids in peripheral blood mononuclear cells of chronic fatigue syndrome patients, without evidence for altered density or affinity of glucocorticoid receptors. J Invest Med 49 (2001) 195-204
65. Gaab J., Rohleder N., Heitz V., et al. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome. Psychoneuroendocrinology 30 (2005) 188-198
66. Lyall M., Peakman M., and Wessely S. A systematic review and critical evaluation of the immunology of chronic fatigue syndrome. J Psychosom Res 55 (2003) 79-90
67. Skowera A., Cleare A., Blair D., Bevis L., Wessely S.C., and Peakman M. High levels of type 2 cytokine-producing cells in chronic fatigue syndrome. Clin Exp Immunol 135 (2004) 294-302
68. Vollmer-Conna U., Cameron B., Hadzi-Pavlovic D., et al. Post-infective fatigue syndrome is not associated with altered cytokine production. Clin Infect Dis 45 (2007) 732-735
69. Hayley S., Merali Z., and Anisman H. Stress and cytokine-elicited neuroendocrine and neurotransmitter sensitization: implications for depressive illness. Stress 6 (2003) 19-32
70. White P.D. What causes chronic fatigue syndrome?. BMJ 329 (2004) 928-929
71. Rief W., and Broadbent E. Explaining medically unexplained symptoms - models and mechanisms. Clin Psychol Rev 27 (2007) 821-841
72. Jones J.F. An extended concept of altered self: chronic fatigue and post-infection syndromes. Psychoneuroendocrinology 33 (2008) 119-129
73. Van Houdenhove B., Verheyen L., Pardaens K., and Van Wambeke P. Decreased motor performance in patients with chronic fatigue syndrome: should we treat low effort capacity or reduced effort tolerance?. Clin Rehabil 21 (2007) 1121-1142
74. Van Houdenhove B, Van Hoof E, Becq K, Kempke S, Luyten P, De Meirleir K. A comparison of patients with chronic fatigue syndrome in two 'ideologically' contrasting clinics. J Nerv Ment Dis, in press.
75. Knoop H., Bleijenberg G., Gielissen M.F., van der Meer J.W., and White P.D. Is a full recovery possible after cognitive behavioural therapy for chronic fatigue syndrome?. Psychother Psychosom 76 (2007) 171-176
76. Roberts A.D., Papadopoulos A.S., Wessely S., Chalder T., and Cleare A.J. Salivary cortisol output before and after cognitive behavioural therapy for chronic fatigue syndrome. J Affect Dis (2008) 10.1016/j.jad.2008.09.01
77. de Lange F.P., Koers A., Kalkman J.S., et al. Increase in prefrontal cortical volume following cognitive behavioural therapy in patients with chronic fatigue syndrome. Brain 131 (2008) 2172-2180
78. Maloney E.M., Gurbaxani B.M., Jones J.F., de Souza Coelho L., Pennachin C., and Goertzel B.N. Chronic fatigue syndrome and high allostatic load. Pharmacogenomics 7 (2006) 467-473
79. Van Damme S., Crombez G., Van Houdenhove B., Mariman A., and Michielsen W. Quality of life in patients with chronic fatigue syndrome: the role of acceptance. J Psychosom Res 61 (2006) 595-599
80. Van Houdenhove B. What is the aim of cognitive behavioural therapy in patients with chronic fatigue syndrome?. Psychother Psychosom 75 (2006) 396-397
81. Van Den Eede F., and Moorkens G. HPA-axis dysfunction in chronic fatigue syndrome: clinical implications. Psychosomatics 49 (2008) 450
82. Bicanic I.A.E., Meijer M., Sinnema G., van de Putte E.M., and Olff M. Neuroendocrine dysregulation in sexually abused children and adolescents: a systematic review. Prog Brain Res 167 (2008) 303-306
83. Sonnenschein M., Mommersteeg P.M., Houtveen J.H., Sorbi M.J., Schaufeli W.B., and van Doornen L.J. Exhaustion and endocrine functioning in clinical burnout: an in-depth study using the experience sampling method. Biol Psychol 75 (2007) 176-184
84. Bellingrath S., Weigl T., and Kudielka B.M. Cortisol dysregulation in school teachers in relation to burnout, vital exhaustion, and effort-reward-imbalance. Biol Psychol 78 (2008) 104-113
85. Bradley R.G., Binder E.B., Epstein M.P., et al. Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry 65 (2008) 190-200
86. Binder E.B., Bradley R.G., Liu W., et al. Association of FKBP5 polymorphisms and childhood abuse with risk of post-traumatic stress disorder symptoms in adults. JAMA 299 (2008) 1291-1305
87. Carlo-Stella N., Badulli C., De Silvestri A., et al. A first study of cytokine genomic polymorphisms in CFS: positive association of TNF-857 and IFNgamma 874 rare alleles. Clin Exp Rheumatol 24 (2006) 179-182
88. Heim C., Young L.J., Newport D.J., Mletzko T., Miller A.H., and Nemeroff C.B. Lower CSF oxytocin concentrations in women with a history of childhood abuse. Mol Psychiatry (2008) 10.1038/mp.2008.11
89. Maunder R.G., and Hunter J.J. Attachment relationships as determinants of physical health. J Am Acad Psychoanal Dyn Psychiatry 36 (2008) 11-32
90. Danese A., Pariante C.M., Caspi A., Taylor A., and Poulton R. Childhood maltreatment predicts adult inflammation in a life-course study. Proc Natl Acad Sci USA 104 (2007) 1319-1324
91. Miller A.H. Mechanisms of cytokine-induced behavioural changes: psychoneuroimmunology at the translational interface. Brain Behav Immun (2008) 10.1016/j.bbi.2008.08.00
92. Dimsdale J.E., and Dantzer R. A biological substrate for somatoform disorders: importance of pathophysiology. Psychosom Med 69 (2007) 850-854
93. Vaccarino V., Brennan M.L., Miller A.H., et al. Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study. Biol Psychiatry 64 (2008) 476-483